CHAPTER 1. Industry Overview of Patient Engagement Solutions Market
1.1. Definition and Scope
1.1.1. Definition of Patient Engagement Solutions
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Patient Engagement Solutions Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Patient Engagement Solutions Market By Delivery Type
1.2.3. Patient Engagement Solutions Market By Component
1.2.4. Patient Engagement Solutions Market By Application
1.2.5. Patient Engagement Solutions Market By Therapeutic Area
1.2.6. Patient Engagement Solutions Market By Functionality
1.2.7. Patient Engagement Solutions Market By End Use
1.2.8. Patient Engagement Solutions Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Application
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Patient Engagement Solutions Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Patient Engagement Solutions Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Price Trend of Key Raw Materials
3.8.1. Raw Material Suppliers
3.8.2. Proportion of Manufacturing Cost Structure
3.8.2.1. Raw Material
3.8.2.2. Labor Cost
3.8.2.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Patient Engagement Solutions Market By Delivery Type
5.1. Introduction
5.2. Patient Engagement Solutions Revenue By Delivery Type
5.2.1. Patient Engagement Solutions Revenue (USD Billion) and Forecast, By Delivery Type, 2020-2032
5.2.2. Cloud-based/Web-based
5.2.2.1. Cloud-based/Web-based Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. On-premise
5.2.3.1. On-premise Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Patient Engagement Solutions Market By Component
6.1. Introduction
6.2. Patient Engagement Solutions Revenue By Component
6.2.1. Patient Engagement Solutions Revenue (USD Billion) and Forecast, By Component, 2020-2032
6.2.2. Software
6.2.2.1. Software Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.2.2. Integrated
6.2.2.2.1. Integrated Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.2.3. Standalone
6.2.2.3.1. Standalone Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Services
6.2.3.1. Services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3.2. Support & Maintenance
6.2.3.2.1. Support & Maintenance Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3.3. Implementation & Training
6.2.3.3.1. Implementation & Training Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3.4. Consulting
6.2.3.4.1. Consulting Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3.5. Others
6.2.3.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Hardware
6.2.4.1. Hardware Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Patient Engagement Solutions Market By Application
7.1. Introduction
7.2. Patient Engagement Solutions Revenue By Application
7.2.1. Patient Engagement Solutions Revenue (USD Billion) and Forecast, By Application, 2020-2032
7.2.2. Population Health Management
7.2.2.1. Population Health Management Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. In-patient Health Management
7.2.3.1. In-patient Health Management Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4. Outpatient Health Management
7.2.4.1. Outpatient Health Management Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.5. Others
7.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. Patient Engagement Solutions Market By Therapeutic Area
8.1. Introduction
8.2. Patient Engagement Solutions Revenue By Therapeutic Area
8.2.1. Patient Engagement Solutions Revenue (USD Billion) and Forecast, By Therapeutic Area, 2020-2032
8.2.2. Chronic Diseases
8.2.2.1. Chronic Diseases Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.3. Mental Health
8.2.3.1. Mental Health Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.4. Women’s Health
8.2.4.1. Women’s Health Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.5. Fitness
8.2.5.1. Fitness Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.6. Others
8.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 9. Patient Engagement Solutions Market By Functionality
9.1. Introduction
9.2. Patient Engagement Solutions Revenue By Functionality
9.2.1. Patient Engagement Solutions Revenue (USD Billion) and Forecast, By Functionality, 2020-2032
9.2.2. Communication
9.2.2.1. Communication Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
9.2.3. Billing & Payments
9.2.3.1. Billing & Payments Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
9.2.4. Health Tracking & Insights
9.2.4.1. Health Tracking & Insights Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
9.2.5. Patient Education
9.2.5.1. Patient Education Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
9.2.6. Administrative
9.2.6.1. Administrative Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
9.2.7. Others
9.2.7.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 10. Patient Engagement Solutions Market By End Use
10.1. Introduction
10.2. Patient Engagement Solutions Revenue By End Use
10.2.1. Patient Engagement Solutions Revenue (USD Billion) and Forecast, By End Use, 2020-2032
10.2.2. Payers
10.2.2.1. Payers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
10.2.3. Individual Users
10.2.3.1. Individual Users Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
10.2.4. Providers
10.2.4.1. Providers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 11. North America Patient Engagement Solutions Market By Country
11.1. North America Patient Engagement Solutions Market Overview
11.2. U.S.
11.2.1. U.S. Patient Engagement Solutions Revenue (USD Billion) and Forecast By Delivery Type, 2020-2032
11.2.2. U.S. Patient Engagement Solutions Revenue (USD Billion) and Forecast By Component, 2020-2032
11.2.3. U.S. Patient Engagement Solutions Revenue (USD Billion) and Forecast By Application, 2020-2032
11.2.4. U.S. Patient Engagement Solutions Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032
11.2.5. U.S. Patient Engagement Solutions Revenue (USD Billion) and Forecast By Functionality, 2020-2032
11.2.6. U.S. Patient Engagement Solutions Revenue (USD Billion) and Forecast By End Use, 2020-2032
11.3. Canada
11.3.1. Canada Patient Engagement Solutions Revenue (USD Billion) and Forecast By Delivery Type, 2020-2032
11.3.2. Canada Patient Engagement Solutions Revenue (USD Billion) and Forecast By Component, 2020-2032
11.3.3. Canada Patient Engagement Solutions Revenue (USD Billion) and Forecast By Application, 2020-2032
11.3.4. Canada Patient Engagement Solutions Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032
11.3.5. Canada Patient Engagement Solutions Revenue (USD Billion) and Forecast By Functionality, 2020-2032
11.3.6. Canada Patient Engagement Solutions Revenue (USD Billion) and Forecast By End Use, 2020-2032
11.4. North America PEST Analysis
CHAPTER 12. Europe Patient Engagement Solutions Market By Country
12.1. Europe Patient Engagement Solutions Market Overview
12.2. U.K.
12.2.1. U.K. Patient Engagement Solutions Revenue (USD Billion) and Forecast By Delivery Type, 2020-2032
12.2.2. U.K. Patient Engagement Solutions Revenue (USD Billion) and Forecast By Component, 2020-2032
12.2.3. U.K. Patient Engagement Solutions Revenue (USD Billion) and Forecast By Application, 2020-2032
12.2.4. U.K. Patient Engagement Solutions Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032
12.2.5. U.K. Patient Engagement Solutions Revenue (USD Billion) and Forecast By Functionality, 2020-2032
12.2.6. U.K. Patient Engagement Solutions Revenue (USD Billion) and Forecast By End Use, 2020-2032
12.3. Germany
12.3.1. Germany Patient Engagement Solutions Revenue (USD Billion) and Forecast By Delivery Type, 2020-2032
12.3.2. Germany Patient Engagement Solutions Revenue (USD Billion) and Forecast By Component, 2020-2032
12.3.3. Germany Patient Engagement Solutions Revenue (USD Billion) and Forecast By Application, 2020-2032
12.3.4. Germany Patient Engagement Solutions Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032
12.3.5. Germany Patient Engagement Solutions Revenue (USD Billion) and Forecast By Functionality, 2020-2032
12.3.6. Germany Patient Engagement Solutions Revenue (USD Billion) and Forecast By End Use, 2020-2032
12.4. France
12.4.1. France Patient Engagement Solutions Revenue (USD Billion) and Forecast By Delivery Type, 2020-2032
12.4.2. France Patient Engagement Solutions Revenue (USD Billion) and Forecast By Component, 2020-2032
12.4.3. France Patient Engagement Solutions Revenue (USD Billion) and Forecast By Application, 2020-2032
12.4.4. France Patient Engagement Solutions Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032
12.4.5. France Patient Engagement Solutions Revenue (USD Billion) and Forecast By Functionality, 2020-2032
12.4.6. France Patient Engagement Solutions Revenue (USD Billion) and Forecast By End Use, 2020-2032
12.5. Spain
12.5.1. Spain Patient Engagement Solutions Revenue (USD Billion) and Forecast By Delivery Type, 2020-2032
12.5.2. Spain Patient Engagement Solutions Revenue (USD Billion) and Forecast By Component, 2020-2032
12.5.3. Spain Patient Engagement Solutions Revenue (USD Billion) and Forecast By Application, 2020-2032
12.5.4. Spain Patient Engagement Solutions Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032
12.5.5. Spain Patient Engagement Solutions Revenue (USD Billion) and Forecast By Functionality, 2020-2032
12.5.6. Spain Patient Engagement Solutions Revenue (USD Billion) and Forecast By End Use, 2020-2032
12.6. Rest of Europe
12.6.1. Rest of Europe Patient Engagement Solutions Revenue (USD Billion) and Forecast By Delivery Type, 2020-2032
12.6.2. Rest of Europe Patient Engagement Solutions Revenue (USD Billion) and Forecast By Component, 2020-2032
12.6.3. Rest of Europe Patient Engagement Solutions Revenue (USD Billion) and Forecast By Application, 2020-2032
12.6.4. Rest of Europe Patient Engagement Solutions Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032
12.6.5. Rest of Europe Patient Engagement Solutions Revenue (USD Billion) and Forecast By Functionality, 2020-2032
12.6.6. Rest of Europe Patient Engagement Solutions Revenue (USD Billion) and Forecast By End Use, 2020-2032
12.7. Europe PEST Analysis
CHAPTER 13. Asia Pacific Patient Engagement Solutions Market By Country
13.1. Asia Pacific Patient Engagement Solutions Market Overview
13.2. China
13.2.1. China Patient Engagement Solutions Revenue (USD Billion) and Forecast By Delivery Type, 2020-2032
13.2.2. China Patient Engagement Solutions Revenue (USD Billion) and Forecast By Component, 2020-2032
13.2.3. China Patient Engagement Solutions Revenue (USD Billion) and Forecast By Application, 2020-2032
13.2.4. China Patient Engagement Solutions Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032
13.2.5. China Patient Engagement Solutions Revenue (USD Billion) and Forecast By Functionality, 2020-2032
13.2.6. China Patient Engagement Solutions Revenue (USD Billion) and Forecast By End Use, 2020-2032
13.3. Japan
13.3.1. Japan Patient Engagement Solutions Revenue (USD Billion) and Forecast By Delivery Type, 2020-2032
13.3.2. Japan Patient Engagement Solutions Revenue (USD Billion) and Forecast By Component, 2020-2032
13.3.3. Japan Patient Engagement Solutions Revenue (USD Billion) and Forecast By Application, 2020-2032
13.3.4. Japan Patient Engagement Solutions Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032
13.3.5. Japan Patient Engagement Solutions Revenue (USD Billion) and Forecast By Functionality, 2020-2032
13.3.6. Japan Patient Engagement Solutions Revenue (USD Billion) and Forecast By End Use, 2020-2032
13.4. India
13.4.1. India Patient Engagement Solutions Revenue (USD Billion) and Forecast By Delivery Type, 2020-2032
13.4.2. India Patient Engagement Solutions Revenue (USD Billion) and Forecast By Component, 2020-2032
13.4.3. India Patient Engagement Solutions Revenue (USD Billion) and Forecast By Application, 2020-2032
13.4.4. India Patient Engagement Solutions Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032
13.4.5. India Patient Engagement Solutions Revenue (USD Billion) and Forecast By Functionality, 2020-2032
13.4.6. India Patient Engagement Solutions Revenue (USD Billion) and Forecast By End Use, 2020-2032
13.5. Australia
13.5.1. Australia Patient Engagement Solutions Revenue (USD Billion) and Forecast By Delivery Type, 2020-2032
13.5.2. Australia Patient Engagement Solutions Revenue (USD Billion) and Forecast By Component, 2020-2032
13.5.3. Australia Patient Engagement Solutions Revenue (USD Billion) and Forecast By Application, 2020-2032
13.5.4. Australia Patient Engagement Solutions Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032
13.5.5. Australia Patient Engagement Solutions Revenue (USD Billion) and Forecast By Functionality, 2020-2032
13.5.6. Australia Patient Engagement Solutions Revenue (USD Billion) and Forecast By End Use, 2020-2032
13.6. South Korea
13.6.1. South Korea Patient Engagement Solutions Revenue (USD Billion) and Forecast By Delivery Type, 2020-2032
13.6.2. South Korea Patient Engagement Solutions Revenue (USD Billion) and Forecast By Component, 2020-2032
13.6.3. South Korea Patient Engagement Solutions Revenue (USD Billion) and Forecast By Application, 2020-2032
13.6.4. South Korea Patient Engagement Solutions Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032
13.6.5. South Korea Patient Engagement Solutions Revenue (USD Billion) and Forecast By Functionality, 2020-2032
13.6.6. South Korea Patient Engagement Solutions Revenue (USD Billion) and Forecast By End Use, 2020-2032
13.7. Rest of Asia-Pacific
13.7.1. Rest of Asia-Pacific Patient Engagement Solutions Revenue (USD Billion) and Forecast By Delivery Type, 2020-2032
13.7.2. Rest of Asia-Pacific Patient Engagement Solutions Revenue (USD Billion) and Forecast By Component, 2020-2032
13.7.3. Rest of Asia-Pacific Patient Engagement Solutions Revenue (USD Billion) and Forecast By Application, 2020-2032
13.7.4. Rest of Asia-Pacific Patient Engagement Solutions Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032
13.7.5. Rest of Asia-Pacific Patient Engagement Solutions Revenue (USD Billion) and Forecast By Functionality, 2020-2032
13.7.6. Rest of Asia-Pacific Patient Engagement Solutions Revenue (USD Billion) and Forecast By End Use, 2020-2032
13.8. Asia Pacific PEST Analysis
CHAPTER 14. Latin America Patient Engagement Solutions Market By Country
14.1. Latin America Patient Engagement Solutions Market Overview
14.2. Brazil
14.2.1. Brazil Patient Engagement Solutions Revenue (USD Billion) and Forecast By Delivery Type, 2020-2032
14.2.2. Brazil Patient Engagement Solutions Revenue (USD Billion) and Forecast By Component, 2020-2032
14.2.3. Brazil Patient Engagement Solutions Revenue (USD Billion) and Forecast By Application, 2020-2032
14.2.4. Brazil Patient Engagement Solutions Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032
14.2.5. Brazil Patient Engagement Solutions Revenue (USD Billion) and Forecast By Functionality, 2020-2032
14.2.6. Brazil Patient Engagement Solutions Revenue (USD Billion) and Forecast By End Use, 2020-2032
14.3. Mexico
14.3.1. Mexico Patient Engagement Solutions Revenue (USD Billion) and Forecast By Delivery Type, 2020-2032
14.3.2. Mexico Patient Engagement Solutions Revenue (USD Billion) and Forecast By Component, 2020-2032
14.3.3. Mexico Patient Engagement Solutions Revenue (USD Billion) and Forecast By Application, 2020-2032
14.3.4. Mexico Patient Engagement Solutions Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032
14.3.5. Mexico Patient Engagement Solutions Revenue (USD Billion) and Forecast By Functionality, 2020-2032
14.3.6. Mexico Patient Engagement Solutions Revenue (USD Billion) and Forecast By End Use, 2020-2032
14.4. Rest of Latin America
14.4.1. Rest of Latin America Patient Engagement Solutions Revenue (USD Billion) and Forecast By Delivery Type, 2020-2032
14.4.2. Rest of Latin America Patient Engagement Solutions Revenue (USD Billion) and Forecast By Component, 2020-2032
14.4.3. Rest of Latin America Patient Engagement Solutions Revenue (USD Billion) and Forecast By Application, 2020-2032
14.4.4. Rest of Latin America Patient Engagement Solutions Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032
14.4.5. Rest of Latin America Patient Engagement Solutions Revenue (USD Billion) and Forecast By Functionality, 2020-2032
14.4.6. Rest of Latin America Patient Engagement Solutions Revenue (USD Billion) and Forecast By End Use, 2020-2032
14.5. Latin America PEST Analysis
CHAPTER 15. Middle East & Africa Patient Engagement Solutions Market By Country
15.1. Middle East & Africa Patient Engagement Solutions Market Overview
15.2. GCC
15.2.1. GCC Patient Engagement Solutions Revenue (USD Billion) and Forecast By Delivery Type, 2020-2032
15.2.2. GCC Patient Engagement Solutions Revenue (USD Billion) and Forecast By Component, 2020-2032
15.2.3. GCC Patient Engagement Solutions Revenue (USD Billion) and Forecast By Application, 2020-2032
15.2.4. GCC Patient Engagement Solutions Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032
15.2.5. GCC Patient Engagement Solutions Revenue (USD Billion) and Forecast By Functionality, 2020-2032
15.2.6. GCC Patient Engagement Solutions Revenue (USD Billion) and Forecast By End Use, 2020-2032
15.3. South Africa
15.3.1. South Africa Patient Engagement Solutions Revenue (USD Billion) and Forecast By Delivery Type, 2020-2032
15.3.2. South Africa Patient Engagement Solutions Revenue (USD Billion) and Forecast By Component, 2020-2032
15.3.3. South Africa Patient Engagement Solutions Revenue (USD Billion) and Forecast By Application, 2020-2032
15.3.4. South Africa Patient Engagement Solutions Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032
15.3.5. South Africa Patient Engagement Solutions Revenue (USD Billion) and Forecast By Functionality, 2020-2032
15.3.6. South Africa Patient Engagement Solutions Revenue (USD Billion) and Forecast By End Use, 2020-2032
15.4. Rest of Middle East & Africa
15.4.1. Rest of Middle East & Africa Patient Engagement Solutions Revenue (USD Billion) and Forecast By Delivery Type, 2020-2032
15.4.2. Rest of Middle East & Africa Patient Engagement Solutions Revenue (USD Billion) and Forecast By Component, 2020-2032
15.4.3. Rest of Middle East & Africa Patient Engagement Solutions Revenue (USD Billion) and Forecast By Application, 2020-2032
15.4.4. Rest of Middle East & Africa Patient Engagement Solutions Revenue (USD Billion) and Forecast By Therapeutic Area, 2020-2032
15.4.5. Rest of Middle East & Africa Patient Engagement Solutions Revenue (USD Billion) and Forecast By Functionality, 2020-2032
15.4.6. Rest of Middle East & Africa Patient Engagement Solutions Revenue (USD Billion) and Forecast By End Use, 2020-2032
15.5. Middle East & Africa PEST Analysis
CHAPTER 16. Player Analysis Of Patient Engagement Solutions Market
16.1. Patient Engagement Solutions MarketCompany Share Analysis
16.2. Competition Matrix
16.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment
16.2.2. New Product Launches and Product Enhancements
16.2.3. Mergers And Acquisition In Global Patient Engagement Solutions Market
16.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 17. Company Profile
17.1. McKesson Corporation
17.1.1. Company Snapshot
17.1.2. Business Overview
17.1.3. Financial Overview
17.1.3.1. Revenue (USD Billion), 2022
17.1.3.2. McKesson Corporation 2022 Patient Engagement Solutions Business Regional Distribution
17.1.4. Product /Service and Specification
17.1.5. Recent Developments & Business Strategy
17.2. Orion Health Ltd.
17.3. Allscripts Healthcare Solutions
17.4. Phytel Inc.
17.5. YourCareUniverse Inc.
17.6. GetWellNetwork Inc.
17.7. Athenahealth Inc.
17.8. Medecision Inc.
17.9. Cerner Corporation
17.10. Lincor Solutions Ltd.
The patient engagement solutions market size was USD 19.2 Billion in 2022.
The CAGR of patient engagement solutions is 16.8% during the analysis period of 2023 to 2032.
The key players operating in the global market are including McKesson Corporation, Orion Health Ltd., Allscripts Healthcare Solutions, Phytel Inc., YourCareUniverse Inc., GetWellNetwork Inc., Athenahealth Inc., Medecision Inc., Cerner Corporation, and Lincor Solutions Ltd.
North America held the dominating position in patient engagement solutions industry during the analysis period of 2023 to 2032.
Asia-Pacific region exhibited fastest growing CAGR for market of patient engagement solutions during the analysis period of 2023 to 2032.
The current trends and dynamics in the patient engagement solutions industry include increasing focus on patient-centered care and shared decision-making, growing adoption of digital health technologies and mobile health apps, and rising prevalence of chronic diseases and the need for proactive healthcare management.
The web and cloud-based delivery type held the maximum share of the patient engagement solutions industry.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date